About Joseph Baron
Form D filings for Atacama Therapeutics in 2024 list Joseph Baron as chief executive officer and director.
Joseph Baron first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Joseph Baron in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Joseph Baron works with at each company, as listed on that company's latest Form D.
Atacama Therapeutics, Inc. · Form D/A, May 7, 2024
JR
Jonathan Reis
Director